Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rossi-Ferrini

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
Haematologica|May 1, 1993
CD34 expression fails to predict the outcome in adult acute myeloid leukemiaS Ciolli, F Leoni, R Caporale, et al.
Acta Haematologica|January 1, 1984
Serum angiotensin-I-converting enzyme and lysozyme levels in untreated and unsplenectomized patients with Hodgkin's diseaseA Bosi, M Borsotti, P Ghelli, et al.
Chemotherapy|March 1, 1993
Ceftriaxone plus conventional or single-daily dose amikacin versus ceftazidime/amikacin as empiric therapy in febrile neutropenic patientsF Leoni, S Ciolli, A Pascarella, et al.
Haematologica|January 1, 1990
Assessment of PTT 119 activity on acute nonlymphoblastic leukemia cells by [3H]-thymidine uptake inhibition and cluster analysisO Dal Pozzo, V Santini, R Saccardi, et al.
Haematologica|January 9, 2001
Fludarabine, cytarabine and topotecan (FLAT) as induction therapy for acute myeloid leukemia in the elderly: a preliminary reportF Leoni, S Ciolli, C Nozzoli, et al.
Lancet (London, England)|May 14, 1988
Prognostic factors in Hodgkin's diseaseA Bosi, A Messori, C Casini, et al.
Lancet (London, England)|September 6, 1986
Half-life and in-vivo recovery of heated factor VIII concentratesM Morfini, A Messori, G Longo, et al.
Computer Methods and Programs in Biomedicine|August 1, 1986
A microcomputer program for individualizing factor VIII dosage in hemophilia patients undergoing major surgeryS Ruffo, A Messori, G Longo, et al.
Cell Biology International Reports|April 1, 1992
Cutaneous venom of Bombina variegata pachypus (Amphibia, Anura): effects on the growth of the human HL 60 cell lineF Balboni, P A Bernabei, C Barberio, et al.
Haematologica|July 1, 1995
Treatment of a delayed graft failure after allogeneic bone marrow transplantation with IL-3 and GM-CSFA M Vannucchi, A Bosi, D Laszlo, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Haematologica|May 1, 1993
CD34 expression fails to predict the outcome in adult acute myeloid leukemiaS Ciolli, F Leoni, R Caporale, et al.
Acta Haematologica|January 1, 1984
Serum angiotensin-I-converting enzyme and lysozyme levels in untreated and unsplenectomized patients with Hodgkin's diseaseA Bosi, M Borsotti, P Ghelli, et al.
Chemotherapy|March 1, 1993
Ceftriaxone plus conventional or single-daily dose amikacin versus ceftazidime/amikacin as empiric therapy in febrile neutropenic patientsF Leoni, S Ciolli, A Pascarella, et al.
Haematologica|January 1, 1990
Assessment of PTT 119 activity on acute nonlymphoblastic leukemia cells by [3H]-thymidine uptake inhibition and cluster analysisO Dal Pozzo, V Santini, R Saccardi, et al.
Haematologica|January 9, 2001
Fludarabine, cytarabine and topotecan (FLAT) as induction therapy for acute myeloid leukemia in the elderly: a preliminary reportF Leoni, S Ciolli, C Nozzoli, et al.
Lancet (London, England)|May 14, 1988
Prognostic factors in Hodgkin's diseaseA Bosi, A Messori, C Casini, et al.
Lancet (London, England)|September 6, 1986
Half-life and in-vivo recovery of heated factor VIII concentratesM Morfini, A Messori, G Longo, et al.
Computer Methods and Programs in Biomedicine|August 1, 1986
A microcomputer program for individualizing factor VIII dosage in hemophilia patients undergoing major surgeryS Ruffo, A Messori, G Longo, et al.
Cell Biology International Reports|April 1, 1992
Cutaneous venom of Bombina variegata pachypus (Amphibia, Anura): effects on the growth of the human HL 60 cell lineF Balboni, P A Bernabei, C Barberio, et al.
Haematologica|July 1, 1995
Treatment of a delayed graft failure after allogeneic bone marrow transplantation with IL-3 and GM-CSFA M Vannucchi, A Bosi, D Laszlo, et al.
Pageof 8